New Breath Test for Celiac Disease Developed by Researchers
Introduction to Celiac Disease
Celiac disease, also known as gluten-sensitive enteropathy, is a chronic autoimmune disorder that primarily impacts the small intestine. Unlike food allergies, celiac disease triggers an adverse immune response to gluten, leading to inflammation and damage to the intestinal lining. This condition hampers the body’s ability to absorb essential nutrients like vitamins and minerals, which are vital for maintaining overall health.
The Challenge of Diagnosing Celiac Disease
Celiac disease is relatively uncommon in Canada, affecting approximately 1% of the population. Symptoms often manifest in infants and children, presenting as diarrhea, vomiting, and abdominal distension. However, recognizing this condition can be challenging due to the nonspecific nature of its symptoms, which can vary widely in severity and manifestation from person to person.
Traditionally, diagnosing celiac disease involves a biopsy of the small intestine, a method that can be invasive, painful, and costly. This procedure can be particularly distressing for children, highlighting the need for a less invasive and more affordable testing method.
Introducing a Non-Invasive Breath Test
To alleviate the anxiety associated with diagnosing gastrointestinal illnesses, a team of researchers from Flinders University in Adelaide, Australia, has developed an innovative breath test aimed at diagnosing celiac disease. Their findings were recently published in the journal Scientific Reports.
This new testing method involves blowing into a glass tube, which measures levels of the dipeptidyl peptidase-4 (DPP4) enzyme in the breath. This enzyme is a specific protein produced in the small intestine that is connected to celiac disease and gut damage. The breath test presents a rapid, real-time, and effective approach to diagnosing the condition, with preliminary lab tests conducted on extracted gas samples showing promising results.
Future Trials and Implications
This breakthrough in diagnostic technology offers a novel avenue for identifying gastrointestinal disorders. The research team is set to initiate trials at the Women’s and Children’s Hospital in Adelaide to assess the accuracy and safety of this breath testing method.
Conclusion
The development of a less invasive and more efficient test for celiac disease could significantly improve the diagnostic process, particularly for children, reducing stress and discomfort associated with traditional methods.
References
Yazbeck, R. et al. Development of a 13C Stable Isotope Assay for Dipeptidyl Peptidase-4 Enzyme Activity A New Breath Test for Dipeptidyl Peptidase Activity. Scientific Reports, 2019;9:4906. DOI: https://doi.org/10.1038/s41598-019-41375-y
Photo credit: Flinders University